The up-regulation of adhesion molecule expressions on monocytes enhances cell-to-cell interactions with T cells, leading to cytokine production. Advanced glycation end products (AGEs) are modifications of proteins/lipids that become nonenzymatically glycated after contact with aldose sugars. Among various subtypes of AGEs, glyceraldehyde-derived AGE (AGE-2) and glycolaldehyde-derived AGE (AGE-3) induce the expressions of intercellular adhesion molecule-1, B7.1, B7.2, and CD40 on monocytes, the production of interferon-␥ and tumor necrosis factor-␣, and the lymphocyte proliferation in human peripheral blood mononuclear cells. Nicotine is reported to inhibit the activation of monocytes via nicotinic acetylcholine receptor ␣7 subunit (␣7-nAChR). In the present study, we found that nicotine inhibited the actions of AGE-2 and AGE-3. A nonselective and selective ␣7-nAChR antagonist, mecamylamine and ␣-bungarotoxin, reversed the inhibitory effects of nicotine, suggesting the involvement of ␣7-nAChR stimulation. Nicotine induced the expression of cyclooxygenase-2, prostaglandin E 2 (PGE 2 ), and cAMP in the presence and absence of AGE-2 and AGE-3. PGE 2 is known to activate the EP 2 /EP 4 receptor, increasing the cAMP level and protein kinase A (PKA) activity. The actions of nicotine were reversed in part by an EP 2 -receptor antagonist, AH6809, an EP 4 -receptor antagonist, AH23848, and a PKA inhibitor, N-[2-(pbromocinnamyl-amino)ethyl]-5-isoquinolinesulfonamide dihydrochloride (H89). These results indicate that the mechanism of action of nicotine may be partially via endogenous PGE 2 production.
back loop (Yamagishi and Imaizumi, 2005) . In a previous study, we found that AGE-2 and AGE-3 induced the expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes, the production of IFN-␥ and TNF-␣, and the lymphocyte proliferation in human PBMCs, but AGE-4 and AGE-5 had no effect (Takahashi et al., 2009a) . The effect of AGE-2 and AGE-3 on the production of IFN-␥ and TNF-␣ depended on cell-to-cell interaction via the engagement between ICAM-1, B7.1, B7.2, and CD40 on monocytes and their ligands on T cells, and the stimulation of RAGEs on monocytes was involved in the actions of AGE-2 and AGE-3 (Takahashi et al., 2009a; Wake et al., 2009) .
Acetylcholine effectively deactivates peripheral macrophages and inhibits the release of proinflammatory mediators. Nicotine activates nAChR belonging to a family of ionotropic receptors consisting of five transmembrane subunits constituting ion channels. Non-neuronal cells such as monocytes and macrophages express nAChR (Wang et al., 2003 (Wang et al., , 2004 . ACh-dependent macrophage deactivation is mediated by ␣7-nAChR, which is expressed in peripheral macrophages and has been described as being essential for the cholinergic anti-inflammatory pathway (Wang et al., 2003 (Wang et al., , 2004 . On the other hand, a major product of COX-initiated arachidonic acid metabolism, PGE 2 , which is released from antigen-presenting cells, primes naive human T cells and enhances their production of anti-inflammatory cytokines while inhibiting their synthesis of pro-inflammatory cytokines (Coleman et al., 1994; Hempel et al., 1994) . Among the four PGE 2 receptor subtypes EP 1 , EP 2 , EP 3 , and EP 4 , activation of EP 2 and EP 4 receptors leads to an increase in cAMP levels and PKA activity (Bastien et al., 1994; Nataraj et al., 2001) . In a previous study, we found that PGE 2 inhibited AGE-2-and AGE-3-induced expressions of ICAM-1, B7.2, and CD40, the production of IFN-␥ and TNF-␣, and the lymphocyte proliferation via the EP 2 and EP 4 receptors (Takahashi et al., 2009b) . The cAMP/PKA pathway was involved in the actions of PGE 2 . Nicotine is reported to induce the expressions of COX-2 and PGE 2 in whole blood and microgria through ␣7-nAChR stimulation (Saareks et al., 1998; De Simone et al., 2005) .
In the present study, we examined the effects of nicotine on AGE-2-and AGE-3-induced expressions of ICAM-1, B7.2, and CD40, the production of IFN-␥ and TNF-␣, and the lymphocyte proliferation in human PBMCs; we also investigated the involvement of PGE 2 production in mediating these effects.
Materials and Methods
Reagents and Drugs. AGE-modified bovine serum albumin (BSA) (Sigma-Aldrich, St Louis, MO) was prepared as described previously (Takeuchi et al., 2000; Takahashi et al., 2009) . In brief, each protein was incubated under sterile conditions with glyceraldehyde 3-phosphate (AGE-2) (Sigma-Aldrich) or glycolaldehyde (AGE-3) (Sigma-Aldrich) in 0.2 M phosphate buffer, pH 7.4, at 37°C for 7 days. AGE-BSA was dialyzed for 2 days at 4°C. The endotoxin concentration of AGEs at 100 g/ml described above was measured at SRL Co. (Okayama, Japan) and was found to be 1.2 pg/ml. AGE-specific fluorescence was measured at 450 nm after excitation at 390 nm with a fluorescence spectrophotometer (Hitachi, Tokyo, Japan). Nicotine (1-methyl-2-(3-pyridyl)pyrrolidine), ␣-bungarotoxin, mecamylamine, H-89, AH6809, and AH23848 (Kay et al., 2006) were purchased from Sigma-Aldrich. NS398 and indomethacin were from Cayman Chemical (Ann Arbor, MI). For flow cytometric analysis, FITC-conjugated mouse IgG1 mAb against ICAM-1/CD54 and phycoerythrin-conjugated anti-CD14 mAb were purchased from Dako Denmark A/S (Glostrup, Denmark). FITC-conjugated mouse IgG1 mAb against B7.2 and CD40 from BD Pharmingen (San Diego, CA), and FITC-conjugated IgG1, an isotype-matched control, was obtained from Sigma-Aldrich.
Isolation of PBMCs and Monocytes. Normal human PBMCs were obtained from 10 healthy volunteers after acquiring institutional review board approval (Okayama University IRB 106). Samples of 20 to 50 ml of peripheral blood were withdrawn from a forearm vein, after which PBMCs were prepared, and monocytes isolated from PBMCs were separated by counterflow centrifugal elutriation as described previously (Takahashi et al., 2003) . The PBMCs and monocytes were then suspended at a final concentration of 1 ϫ 10 6 cells/ml in the medium as described previously (Takahashi et al., 2003) .
Flow Cytometric Analysis for Adhesion Molecule Expression. Changes in the expressions of human leukocyte antigens, ICAM-1, B7.1, B7.2, CD40 and CD40L, on monocytes were examined by multicolor flow cytometry by use of a combination of anti-CD14 Ab with anti-ICAM-1, anti-B7.1, anti-B7.2, anti-CD40, or anti-CD40L Ab. PBMCs at 1 ϫ 10 6 cells/ml were incubated for 24 h. Cultured cells at 5 ϫ 10 5 cells/ml were prepared for flow cytometric analysis as described previously (Takahashi et al., 2003) and analyzed with a FACSCalibur (BD Biosciences, San Jose, CA). The data were processed by use of the CellQuest program.
ELISA Assays. PBMCs at 1 ϫ 10 6 cells/ml were used to analyze IFN-␥ and TNF-␣ production, and monocytes at 1 ϫ 10 6 cells/ml were used to analyze PGE 2 production. After culturing for 24 h at 37°C in a 5% CO 2 /air mixture, cell-free supernatants were assayed for IFN-␥, TNF-␣ (R&D Systems, Minneapolis, MN) and PGE 2 protein (Cayman Chemical) by ELISA using the multiple Abs sandwich principle. The detection limits of ELISA for IFN-␥, TNF-␣, and PGE 2 were 10 pg/ml. Proliferation Assay. PBMCs were divided into 96-well microplates, 200 l/well, and were incubated with various conditions for 48 h, during which they were pulsed with 1 Ci of [ 3 H]thymidine per well for the final 16 h. Then, the cells were harvested by the MicroMate 196 Cell Harvester (PerkinElmer Life and Analytical Sciences, Waltham, MA). Thymidine incorporation was measured by a ␤-counter (Matrix 9600; PerkinElmer Life and Analytical Sciences).
Western Immunoblotting. Monocytes at 1 ϫ 10 6 cells/ml were incubated with nicotine in the presence or absence of AGE-2 and AGE-3 at 37°C in a 5% CO 2 -air mixture for 30 min. After incubation, the cells were washed twice in phosphate-buffered saline before the addition of 60 l of ice-cold lysis buffer (HEPES-buffered Hanks' balanced salt solution, pH 7.4, 0.5% Triton X-100, 10 mg/ml leupeptin, 10 mg/ml aprotinin) and 60 l of sample buffer (0.125 M Trizma base, pH 6.8, 20% glycerol, 4% SDS, 10% 2-mercaptoethanol). The samples were then heated at 95°C for 7 min before being stored at 20°C. Sample proteins (50 ml/lane) were separated on 9% acrylamide gel and transferred onto Trans-Blot membranes at 4°C for 16 h at 300 mA, after which the membranes were blocked for 1 h at 25°C in Tris-buffered saline (25 mM Tris-HCl, 0.2 M NaCl, 0.15% Tween 20, pH 7.6) containing 5% dried milk (wt/vol). Next, the membranes were treated with horseradish peroxidase-conjugated rabbit polyclonal Ab against human COX-2 (Cayman Chemical) and ␤-actin (Sigma-Aldrich).
Measurement of cAMP Production in Monocytes. Monocytes at 1 ϫ 10 6 cells/ml were incubated at 37°C in a 5% CO 2 /air mixture. After 30 min, cells at 2 ϫ 10 5 cells/200 l/well were supplemented with trichloroacetic acid to a final concentration of 5% and 3-isobutyl-1-methylxanthine, an inhibitor of phosphodiesterase at 100 M and frozen at Ϫ80°C. Frozen samples were subsequently sonicated and assayed for cAMP by use of a cAMP enzyme immunoassay kit (Cayman Chemical) according to the manufacturer's instructions, for which no acetylation procedures were performed.
Statistical Analysis. Statistical significances were evaluated using ANOVA followed by Dunnett's test. A probability value of less than 0.05 was considered to indicate statistical significance. The results are expressed as the means Ϯ S.E.M. of triplicate findings from five donors.
Results
Effects of Nicotine on AGE-2-and AGE-3-Induced Expression of ICAM-1, B7.1, B7.2, and CD40 on Monocytes, the Production of IFN-␥ and TNF-␣ in PBMCs, and the Proliferation in PBMCs. In the previous study, to evaluate the binding of AGE subtypes to RAGE, we established an in vitro assay using immobilized AGE subspecies and the His-tagged soluble form of RAGE (sRAGE) protein (Takahashi et al., 2009a) . AGE-2 and AGE-3 showed relatively high-affinity binding for sRAGE, whereas AGE-4 and AGE-5 showed moderate affinity for sRAGE. The appropriate incubation time and concentration of AGEs were determined according to the studies reported (Takahashi et al., 2009a; Wake et al., 2009 ). To determine appropriate incubation time, we examined the kinetics at 0, 4, 16, 24, and 48 h. In the absence of AGEs, the expression of ICAM-1, B7.1, B7.2, and CD40 moderately increased at 16 h and thereafter up to 24 and 48 h. AGE-2 and AGE-3 at 100 g/ml significantly induced the expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes, the production of IFN-␥ and TNF-␣ in PBMCs, and the proliferation in PBMCs at 16 h and thereafter up to 24 and 48 h, whereas AGE-4, AGE-5, and BSA at 100 g/ml had no effect at all (Takahashi et al., 2009; Wake et al., 2009) . Moreover, to determine the appropriate concentration of AGEs, the effects of AGE-2 and AGE-3 at concentrations ranging from 100 ng/ml to 100 g/ml for 24 h were examined. AGE-2 and AGE-3 at 10 and 100 g/ml significantly induced the expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes, the production of IFN-␥ and TNF-␣ in PBMCs, and the proliferation in PBMCs (Takahashi et al., 2009a; Wake et al., 2009) .
As shown in Figs. 1 and 2, we established the effect of nicotine at concentrations ranging from 0.1 to 100 M on 100 g/ml AGE-2-and AGE-3-induced expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes, the production of IFN-␥ and TNF-␣ and the lymphocyte proliferation in PBMCs. Nicotine concentration-dependently inhibited AGE-2-and AGE-3-induced expressions of ICAM-1, B7.1, B7.2, and CD40 (Fig.  1, A and B) , the production of IFN-␥ and TNF-␣, and the lymphocyte proliferation (Fig. 2, A and B) . IC 50 values for the inhibitory effect of nicotine on the expressions of ICAM-1, B7.1, B7.2, and CD40, the production of IFN-␥ and TNF-␣, and the lymphocyte proliferation in the presence of AGE-2 were 2, 1, 1, 2, 0.9, 1, and 0.9 M, and those in the presence of AGE-3 were 1, 1, 2, 1, 0.9, 1, and 1 M, respectively. In the presence of BSA at 100 g/ml, nicotine had no effect on the expressions of adhesion molecule (Fig. 1C) , cytokine production, and lymphocyte proliferation (Fig. 2C) .
Effects of ␣7-nAChR Antagonists on the Actions of Nicotine. To determine the involvement of ␣7-nAChR in nicotine activity, we examined the effect of a nonselective ␣7-nAChR antagonist, mecamylamine, and a selective ␣7-nAChR antagonist, ␣-bungarotoxin, ranging from 0.1 to 100 M on 100 M nicotine-induced inhibition of ICAM-1, B7.1, Fig. 1 . The effects of nicotine on AGE-2-, AGE-3-, and BSA-induced expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes. PBMCs at 1 ϫ 10 6 cells/ml were incubated with AGE-2 (A), AGE-3 (B), and BSA (C) at 100 g/ml and nicotine at increasing concentrations from 0.1 to 100 M for 24 h. The expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes were determined by flow cytometry. FITC-conjugated IgG1 was used as an isotypematched control Ab. Filled circles represent the effect of nicotine on the adhesion molecule expression and cytokine production in the presence of AGE-2 and AGE-3. Open circles represent the effect of nicotine in the absence of AGE-2 and AGE-3. The results are expressed as the means Ϯ S.E.M. of five donors with triplicate determinations. ‫,ء‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01 compared with the value for AGE-2 and AGE-3. When an error bar is within a symbol, the bar was omitted.
Effect of Nicotine on AGEs-Treated Monocytes
B7.2, and CD40 expressions on monocytes (Fig. 3) , the production of TNF-␣ and IFN-␥, and the lymphocyte proliferation in PBMCs (Fig. 4) in the presence or absence of AGE-2 and AGE-3 at 100 g/ml. The ␣7-nAChR antagonists reversed the inhibitory effects of nicotine. Mecamylamine and ␣-bungarotoxin had no effect in the absence of nicotine (data not shown).
Effects of Nicotine on Expression of COX-2 and Production of PGE 2 in Monocytes. As shown in Fig. 5A , nicotine at 100 M induced the expression of COX-2 in monocytes in the presence or absence of AGE-2 and AGE-3 at 100 g/ml, but AGE-2 or AGE-3 alone had no effect. As shown in Fig. 5 , B and C, nicotine induced PGE 2 production in monocytes in the presence or absence of AGE-2 and AGE-3, but AGE-2 or AGE-3 alone had no effect. Mecamylamine (Fig.  5D ) and ␣-bungarotoxin (Fig. 5E ) prevented nicotine-stimulated PGE 2 production in the presence or absence of AGE-2 and AGE-3. Without nicotine, ␣7-nAChR antagonist inhibitors had no effect on PGE 2 production (data not shown). A nonselective or a selective COX-2 inhibitor, indomethacin (Fig. 5F ) or NS398 (Fig. 5G) , inhibited nicotine-induced PGE 2 production in the presence or absence of AGE-2 and AGE-3, but a PKA inhibitor, H89, had no effect (data not shown). Without nicotine, these inhibitors had no effect on PGE 2 production (data not shown). The effects of nicotine on AGE-2-, AGE-3-, and BSA-induced production of IFN-␥ and TNF-␣ and the lymphocyte proliferation in PBMCs. PBMCs at 1 ϫ 10 6 cells/ml were incubated with AGE-2 (A), AGE-3 (B), and BSA (C) at 100 g/ml and nicotine at increasing concentrations from 0.1 to 100 M for 24 h. IFN-␥ and TNF-␣ concentrations in conditioned media were determined by ELISA. The lymphocyte proliferation was determined by [ 3 H]thymidine uptake as described under Materials and Methods. A-C, filled circles represent the effect of nicotine on adhesion molecule expression and cytokine production in the presence of AGE-2 and AGE-3. A, open circles represent the effect of nicotine in the absence of AGE-2 and AGE-3. The results are expressed as the means Ϯ S.E.M. of five donors with triplicate determinations. ‫,ءء‬ P Ͻ 0.01 compared with the value for AGE-2 and AGE-3. When an error bar is within a symbol, the bar was omitted. Fig. 3 . The effect of ␣7-nAChR antagonists on the effect of nicotine on the expressions of ICAM-1, B7.1, B7.2, and CD40. The effect of a nonselective ␣7-nAChR antagonist, mecamylamine (F), or a selective ␣7-nAChR antagonist, ␣-bungarotoxin (E), at increasing concentrations ranging from 0.01 to 10 nM on the actions of nicotine at 100 M in the presence of AGE-2 (A) and AGE-3 (B) at 100 g/ml. The expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes were determined by flow cytometry. The results are expressed as the means Ϯ S.E.M. of triplicate findings from five donors. ‫,ء‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01 compared with the value for AGE-2 and AGE-3. When an error bar is within a symbol, the bar was omitted. Fig. 4 . The effect of ␣7-nAChR antagonists on the effect of nicotine on the production of IFN-␥ and TNF-␣ and the lymphocyte proliferation. The effect of a nonselective ␣7-nAChR antagonist, mecamylamine (F), or a selective ␣7-nAChR antagonist, ␣-bungarotoxin (E), at increasing concentrations ranging from 0.01 to 10 nM on the actions of nicotine at 100 M in the presence of AGE-2 (A) and AGE-3 (B) at 100 g/ml. IFN-␥ and TNF-␣ concentrations in conditioned media were determined by ELISA. The lymphocyte proliferation was determined by [ 3 H]thymidine uptake as described in Materials and Methods. The results are expressed as the means Ϯ S.E.M. of triplicate findings from five donors. ‫,ء‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01 compared with the value for AGE-2 and AGE-3. When an error bar is within a symbol, the bar was omitted.
Effects of Nicotine on the Activation of cAMP in Monocytes.
In the presence or absence of AGE-2 and AGE-3 at 100 g/ml, nicotine at 100 M significantly activated intracellular cAMP in monocytes at 15 min and thereafter up to 30 and 60 min (Fig. 6A ). As shown in Fig. 6B , ␣7-nAChR antagonists, mecamylamine and ␣-bungarotoxin, prevented nicotine-induced activation of cAMP in the presence or absence of AGE-2 and AGE-3. COX-2 inhibitors, indomethacin and NS398, also reversed the nicotine-enhanced activation of cAMP in the presence or absence of AGE-2 and AGE-3. In the absence of nicotine, ␣7-nAChR antagonists and COX-2 inhibitors had no effect on the activation of cAMP (data not shown).
Involvement of Prostanoid EP 2 and EP 4 Receptors in the Actions of Nicotine. To determine the involvement of PGE 2 receptor subtypes in the effects of nicotine on the expressions of ICAM-1, B7.1, B7.2, and CD40, the production of IFN-␥ and TNF-␣ and the lymphocyte proliferation, the effect of an EP 2 -receptor antagonist, AH6809 (Kay et al., 2006; Takahashi et al., 2009b) and an EP 4 -receptor antagonist, AH23848 (Kay et al., 2006; Takahashi et al., 2009b) at concentrations ranging from 0.1 to 100 M in the presence of nicotine at 100 M were examined (Figs. 7 and 8 ). AH6809 and AH23848 reversed the inhibitory effect of nicotine on AGE-2-and AGE-3-induced expressions of ICAM-1, B7.1, B7.2, and CD40 (Fig. 7) , the production of IFN-␥ and TNF-␣, and the lymphocyte proliferation (Fig. 8) in a concentrationdependent manner. The effect of AH6809 on the actions of nicotine was stronger than that of AH23848. On the other hand, AH6809 and AH23848 had no effect on the actions of AGE-2 and AGE-3 in the absence of nicotine.
Involvement of COX-2 and PKA in the Action of Nicotine. To investigate the involvement of COX-2 and PKA in Fig. 6 . The effect of nicotine on the activation of cAMP in monocytes. A, the time course effect of nicotine at 100 M on production of cAMP was determined by ELISA. Monocytes at 1 ϫ 10 6 cells/ml were incubated with AGE-2 (F), AGE-3 (E), and BSA (Ⅺ) at 100 g/ml and nicotine at 100 M for 24 h. B, the effect of ␣7-nAChR antagonists, mecamylamine or ␣-bungarotoxin, at 10 nM and the COX-2 inhibitors, indomethacin and NS398, at 100 M on 100 M nicotine-induced production of cAMP in the presence of AGE-2, AGE-3, and BSA at 100 g/ml was determined. ‫,ءء‬ P Ͻ 0.01 compared with the value for BSA alone; ##, P Ͻ 0.01 compared with the value for nicotine. The results are the means Ϯ S.E.M. of triplicate findings from five donors. ND, not detected.
Fig. 5.
The effect of nicotine on the expression of COX-2 and the production of PGE 2 in monocytes. A, monocytes at 1 ϫ 10 6 cells/ml were incubated with nicotine at 100 M in the presence or absence of AGE-2, AGE-3, and BSA at 100 g/ml for 30 min. The expression of COX-2 protein was determined by Western immunoblotting as described under Materials and Methods. ␤-Actin was used as control to correct for loading. The concentration of PGE 2 was determined by ELISA. B, the time course effect of nicotine on PGE 2 production was determined. Monocytes at 1 ϫ 10 6 cells/ml were incubated with nicotine at 100 M in the presence of AGE-2, AGE-3, and BSA at 100 g/ml for the indicated periods. C, the effect of nicotine at increasing concentrations from 0.1 to 100 M in the presence of AGE-2, AGE-3, and BSA at 100 g/ml for 24 h was determined. D-G, the effect of a nonselective ␣7-nAChR antagonist, mecamylamine (D); a selective ␣7-nAChR antagonist, ␣-bungarotoxin (E); a nonselective COX-2 inhibitor, indomethacin (F); and a selective COX-2 inhibitor, NS398 (G), on the actions of nicotine at 100 M was determined. Filled circles represent the effect of nicotine on PGE 2 production in the presence of AGE-2, open circles represent that effect in the presence of AGE-3, and open squares represent that effect in the presence of BSA. The results are expressed as the means Ϯ S.E.M. of five donors with triplicate determinations. When an error bar is within a symbol, the bar is omitted.
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at ASPET Journals on September 23, 2017 jpet.aspetjournals.org Downloaded from the inhibitory effect of nicotine on the expressions of ICAM-1, B7.1, B7.2, and CD40, the production of IFN-␥ and TNF-␣, and the lymphocyte proliferation, we examined the effect of COX-2 and PKA inhibitors (Figs. 9 and 10 ). COX-2 inhibitors, indomethacin and NS398, and the PKA inhibitor, H89, reversed the inhibitory effect of nicotine on the expressions of adhesion molecule (Fig. 9) , the production of IFN-␥ and TNF-␣, and the lymphocyte proliferation (Fig. 10) in the presence of AGE-2 and AGE-3. COX-2 and PKA inhibitors had no effect on AGE-2-and AGE-3-induced adhesion molecule expression and cytokine production in the absence of nicotine (data not shown).
Discussion
The level of AGE-2 is reported to be 17 g/ml in the serum of patient with diabetes (Enomoto et al., 2006; Nakamura et al., 2007) . It is reported that AGEs at the concentrations ranging from 50 to 200 g/ml remarkably induce human monocyte adhesion to bovine retinal endothelial cells (Mamputu and Renier, 2004) . AGEs at 200 g/ml induce the expression of CD40, CD80 and CD86 and the production of IFN-␥ in dendritic cells (Ge et al., 2005) . In the previous study, we found that AGE-2 and AGE-3 at 10 and 100 g/ml significantly up-regulated the expressions of ICAM-1, B7.1, B7.2 and CD40, the production of IFN-␥ and TNF-␣ and the lymphocyte proliferation (Takahashi et al., 2009a; Wake et al., 2009) . Therefore, the concentration (100 g/ml) used in the present study may be not far above the pathological concentration of AGEs in the serum of patient with diabetes reported in the studies (Enomoto et al., 2006; Nakamura et al., 2007) .
We found that AGE-2 and AGE-3 induced the production of IFN-␥ and TNF-␣ in monocytes isolated from PBMCs, exhibiting 20% of the amount obtained in PBMCs (Takahashi et al., 2009a) . AGE-2 and AGE-3 had no effect on the production of IFN-␥ and TNF-␣ in T cells isolated from PBMCs. Anti-ICAM-1, anti-B7.1, anti-B7.2, and anti-CD40 Abs inhibited the AGE-2-and AGE-3-induced production of IFN-␥ and TNF-␣ in PBMCs. We suggested that AGE-2-and AGE-3-induced cytokine production required the enhancement of cellto-cell interaction between monocytes and T cells through the induction of plural adhesion molecule expression on monocytes. Together with these results, we examined the effect of nicotine on AGE-2-and AGE-3-induced expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes, the production of IFN-␥ and TNF-␣ in PBMCs, and the lymphocyte proliferation in PBMCs.
As shown in Figs. 1 and 2 , we found that nicotine prevented 100 g/ml AGE-2-and AGE-3-induced expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes, the production of IFN-␥ and TNF-␣, and the lymphocyte proliferation in PBMCs. In the presence of AGE-2 and AGE-3 at 10 g/ml, nicotine also inhibited expressions of ICAM-1, B7.1, B7.2, and CD40, the produc- PBMCs at 1 ϫ 10 6 cells/ml treated with nicotine at 100 M were incubated with the EP 2 -receptor antagonist AH6809 (A) and the EP 4 -receptor antagonist AH23848 (B) at increasing concentrations from 0.1 to 100 M in the presence of AGE-2 and AGE-3 at 100 g/ml. The expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes were determined by flow cytometry. Filled circles represent the effect of antagonists on nicotineinhibited adhesion molecule expression in the presence of AGE-2. Open circles represent the effect of antagonists on nicotine-inhibited adhesion molecule expression in the presence of AGE-3. Filled squares represent the effect of antagonists on the actions of AGE-2 in the absence of nicotine. Open squares represent the effect of antagonists on the actions of AGE-3 in the absence of nicotine. The results are expressed as the means Ϯ S.E.M. of five donors with triplicate determinations. ‫,ء‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01 compared with the value for nicotine in the presence of AGE-2 and AGE-3. When an error bar is within a symbol, the bar was omitted. Fig. 8 . The effects of prostanoid receptor antagonists on the inhibitory effect of nicotine on the production of IFN-␥ and TNF-␣ and the lymphocyte proliferation. PBMCs at 1 ϫ 10 6 cells/ml treated with nicotine at 100 M were incubated with the EP 2 -receptor antagonist AH6809 (A) and the EP 4 -receptor antagonist AH23848 (B) at increasing concentrations from 0.1 to 100 M in the presence of AGE-2 and AGE-3 at 100 g/ml. IFN-␥ and TNF-␣ concentrations in conditioned media were determined by ELISA. The lymphocyte proliferation was determined by [ tion of IFN-␥ and TNF-␣, and the lymphocyte proliferation in a concentration-dependent manner (data not shown). The IC 50 values of nicotine for the inhibition of adhesion molecule and cytokine production were within the range of the concentration reported to be effective in recent animal studies (Wang et al., 2003 (Wang et al., , 2004 . It is suggested that vagus nerve stimulation modulates the immune response and controls inflammation through a nicotinic anti-inflammatory pathway dependent on ␣7-nAChR (de Jonge et al., 2005; Saeed et al., 2005) . ␣7-nAChR is required for acetylcholine inhibition of lipopolysaccharide-induced TNF-␣ production in human macrophages (Wang et al., 2003) . In the present study, we found that ␣7-nAChR antagonists reversed the inhibitory effect of nicotine on the expressions of ICAM-1, B7.1, B7.2, and CD40, the production of IFN-␥ and TNF-␣ and the lymphocyte proliferation in the presence of AGE-2 and AGE-3 (Figs. 3 and 4) . This suggests that inhibitory effects of nicotine depend on the stimulation of ␣7-nAChR.
We further investigated the action mechanism of nicotine. PGE 2 , which is released from antigen-presenting cells, acts on naive human T cells to enhance their production of antiinflammatory cytokines (Hempel et al., 1994; Coleman et al., 1994) . PGE 2 , a product of COX-2-initiated metabolism, is known to activate the cAMP/PKA pathway (Bastien et al., 1994; Nataraj et al., 2001) . As shown in Fig. 5, A and B, we found that nicotine induced the expression of COX-2 and the production of PGE 2 in the presence or absence of AGE-2 and AGE-3. The ␣7-nAChR and COX-2 inhibitors prevented nicotine-initiated PGE 2 production in the presence or absence of AGE-2 and AGE-3 (Fig. 5, C-F) . These results suggest that the effect of nicotine on the expression of COX-2 and the production of PGE 2 depends on the stimulation of ␣7-nAChR. We also determined the levels of other COX-2 metabolites, including PGE 1 , PGD2, PGF 2 , PGI 2 , PGJ 2 , and thromboxane, measured in monocyte medium treated with nicotine in the presence or absence of AGE-2 and AGE-3, but all were under the level of detection (data not shown). As shown in Fig. 6A , nicotine activated intracellular cAMP in monocytes in the presence or absence of AGE-2 and AGE-3. ␣7-nAChR antagonists and COX-2 inhibitors prevented this nicotineinduced activation of cAMP in the presence or absence of AGE-2 and AGE-3 (Fig. 6B) , suggesting the involvement of ␣7-nAChR stimulation and COX-2 production in nicotineinduced elevation of cAMP.
In the previous study, we reported that PGE 2 inhibited AGE-2-and AGE-3-enhanced expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes, the production of IFN-␥ and TNF-␣, and the lymphocyte proliferation in PBMCs (Taka- Fig. 9 . The involvement of COX-2 and PKA in the effect of nicotine on the expressions of ICAM-1, B7.1, B7.2, and CD40. The effect of COX-2 inhibitors, indomethacin (A) and NS398 (B), and a PKA inhibitor, H89 (C), at increasing concentrations ranging from 0.1 to 100 M on the actions of nicotine at 100 M in the presence of AGE-2 (F) and AGE-3 (E) at 100 g/ml. The expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes were determined by flow cytometry. The results are expressed as the means Ϯ S.E.M. of triplicate findings from five donors. ‫,ءء‬ P Ͻ 0.01 compared with the value for nicotine. When an error bar is within a symbol, the bar was omitted. , 2009b) . Among the four subtypes of receptors: prostanoid EP 1 , EP 2 , EP 3 , and EP 4 receptors, the EP 2 and EP 4 receptors were involved in the actions of PGE 2 . In the previous study, we found that the EP 2 -receptor antagonist, AH6809 and the EP 4 -receptor antagonist, AH23848, inhibited the actions of PGE 2 (Takahashi et al., 2009b ). An EP 2 -receptor agonist, ONO-AE1-259-01 and an EP 4 -receptor agonist, ONO-AE1-329 mimicked the actions of PGE 2 . In the presence of AGE-2 and AGE-3, PGE 2 induced the elevation of cAMP via EP 2 and EP 4 receptor. Moreover, the PKA inhibitor, H89, inhibited the action of PGE 2 , and a membranepermeable cAMP analog, dibutyryl cAMP, and an adenylate cyclase activator, forskolin, mimicked the effect of PGE 2 . These results suggested the involvement of the EP 2 /EP 4 -receptors-cAMP/PKA pathway in the actions of PGE 2 .
In the present study, we found that the EP 2 -receptor antagonist, AH6809 and the EP 4 -receptor antagonist, AH23848, inhibited the actions of nicotine (Figs. 7 and 8 ). As shown in Figs. 9 and 10, COX-2 or PKA inhibitors partially reversed the inhibitory effect of nicotine on the expressions of ICAM-1, B7.1, B7.2, and CD40 on monocytes, the production of IFN-␥ and TNF-␣, and the lymphocyte proliferation in PBMCs in the presence of AGE-2 and AGE-3. These results imply that the additional increase in PGE 2 by the combination of nicotine and AGEs might, at least partially account for the suppressive effect of nicotine on AGE-2-and AGE-3-induced enhancement of adhesion molecule expressions and cytokine production. We observed a similar pattern of inhibitory effects of nicotine on lipopolysaccharide (LPS)-and interleukin (IL)-18-induced activation of monocytes in human PBMCs via ␣7-nAChR Takahashi et al., 2006) . Nicotine induced PGE 2 production in monocytes treated with LPS and IL-18 via ␣7-nAChR. COX-2 and PKA inhibitors prevented the effects of nicotine on adhesion molecule expression and cytokine production. Thus, there may be a partially common pathway triggered by LPS, IL-18, and AGEs that is regulated by the ␣7-nAChR-PGE 2 -cAMP/PKA system. Further work is necessary on this issue.
Nicotine by it own did not inhibit basal production of IFN-␥ and TNF-␣ in the absence of AGE-2 and AGE-3 (Fig. 2) . As shown in Fig. 5 , nicotine at 100 M induced production of PGE 2 at 4.7 nM in the absence of AGE-2 and AGE-3. Exogenous PGE 2 at 5 nM had no effect on the production of IFN-␥ and TNF-␣ in the absence of AGE-2 and AGE-3 (data not shown). Therefore, 100 M nicotine-induced PGE 2 might not effect on IFN-␥ and TNF-␣ production.
In the previous study, using of an in vitro binding assay, we found that AGE-2 and AGE-3 had higher affinity for RAGEs than AGE-4 and AGE-5 (Takahashi et al., 2009a) . AGE-2 and AGE-3, but not AGE-4 and AGE-5, induced the up-regulation of their receptor RAGE expression on the cell surface of monocytes. Nicotine had no effect on the expression of RAGEs in the presence and absence of AGE-2 and AGE-3 (data not shown), suggesting that there might be distinct signal transduction pathways of RAGE activation, leading to enhanced expressions of adhesion molecule and RAGEs, which were differentially regulated by the cAMP/ PKA system. It is reported that AGEs and RAGEs are detected in atherosclerotic plaque of diabetic patients (Cuccurullo et al., 2006) . RAGEs are reported to be expressed by smooth muscle cells (SMCs) as well as endothelial cells, monocytes, macrophages, mesangial cells, and nerve cells (Brett et al., 1993) . AGEs directly stimulate proliferation not in endothelial cells, but in SMCs (Satoh et al., 1997) . It is reported that PGE 2 induced by monocytes inhibits procollagen secretion by human vascular SMCs, leading to extracellular matrix remodeling and resistance to rupture during atherosclerosis (Fitzsimmons et al., 1999) . Elevation of cAMP in endothelial cells inhibits proliferation, leading to the inhibition of atherosclerosis in patients with diabetes (Lorenowicz et al., 2007) . Nicotine exerts its atherogenic effects in part through the increase of SMC proliferation and migration (Carty et al., 1997; Di Luozzo et al., 2005) . ␣7-nAChR is detected in the rat arterial system and in SMCs derived from brain basilar arteries (Brü ggmann et al., 2003; Li et al., 2004) , indicating that stimulation of ␣7-nAChR induces the proliferation of SMCs. Together with these results and our data, other extracellular stimuli, which induce intracellular cAMP production upon binding to their cognate G protein-coupled receptors, may regulate the activation of vascular smooth muscle cells and endothelial cells. However, ␣7-nAChR stimulation may inhibit the activation of monocytes. Further study of the role of ␣7-nAChR in the stimulation of SMCs and monocytes should be continued.
In conclusion, we found that nicotine inhibited AGE-2-and AGE-3-enhanced adhesion molecule expressions, the cytokine production, and the lymphocyte proliferation via ␣7-nAChR. The COX-2-PGE 2 -cAMP/PKA system may be involved, in part, in the actions of nicotine. Through the inhibition of toxic AGE-dependent responses in monocytes, the stimulation of ␣7-nAChR may partially contribute to regulation of the development of atherosclerotic plaques in diabetes.
